Stem Cell Therapy is known as regenerative medicine, it has a unique property of regeneration in the cell. Stem cell therapy are having two categories, the first one is embryonic and the second one is adult stem cell, and based on the property of regeneration the stem cell are having another categories like Multipotent, Pluripotent, Unipotent cell and others. Stem cell therapy is used in various treatment like blood cancer, Alzheimer, Stroke, Spinal Cord Injury and many others. Many players are working in the R&D of stem cell to come up with various treatment product for animals. Players are initially focusing on the arthritis problem solving in the canine and other animals. The extraction of stem cell are done from human umbilical cord tissue, bone marrow and adipose tissue. The advancement in the treatment of canine is also coming with mixing of two therapy as PRP and stem cell for modulating inflammation and regeneration of damage tissue. Further many other combined therapy are coming in the market for the treatment of canine from all type of diseases.
Canine Stem Cell Therapy: Drivers & Restraints
Canine Stem Cell Therapy Market is a developing market as many product are having their present in the market. The demand of canine stem cell therapy is high, for instance, a report published by Metropolitan Veterinary Center, Chicago, around 155 canines suffering from osteoarthritis were treated with stem cell therapy, and 99% of the canines show improvement. Players and research institutes are working to develop a products to treat the other diseases of canine like canine cognitive dysfunctions which is similar to Alzheimer’s dementia. The costing and the reimbursement is the current restraints and also the awareness of canine stem cell therapy in the current market.
Canine Stem Cell Therapy: Segmentation
Segmentation by Product Type
Xenogeneic, Allogeneic, Autologous, Type 1, Type 2
Segmentation by End User
Veterinary Hospitals, Veterinary Clinics, Veterinary Research Institutes
Based on Geography
North America, Europe, Latin America, Asia-Pacific, Middle East and Africa
The market of canine stem cell therapy is a growing market over the forecast period. As the players coming with the product and show high success rate of treatment. As the animal welfare act law came in 1966 in the U.S, than after that the societies are more taking care of the animal. One of the players name as Regeneus Ltd, from Australia is coming with the product for canine for the treatment of osteoarthritis and tendinopathy name as CryoShot Canine. CryoShot canine is for osteoarthritis and provide pain relief for a longer time a single injection. Various clinical research and advanced technology combination are going on for canine diseases treatments like diabetes, cancer and others, the final product will also available soon in the market.
A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/15550
As a geography conditions the Canine Stem Cell Therapy Market is segmented into: North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. North America have the market for canine stem cell therapy as the population are much aware of the therapy and take caring of the animals, and many help line are also there for animals like Pet Poison Helpline, USA and many others. Asia-pacific is also the market for canine stem cell therapy as
Some players in Canine Stem Cell Therapy Market is VETSTEM BIOPHARMA, Aratana Therapeutics, Medivet Biologics LLC , Okyanos, Vetbiologics, VetMatrix, Magellan Stem Cells, ANIMAL CELL THERAPIES, INC., stemcellvet.co.uk., Cell Therapy Sciences, and Regeneus Ltd.
Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/15550